Interleukin-23 (IL-23) is essential for the differentiation of pathogenic effector T helper 17 (Th17) cells, but its role in memory Th17 cell responses is unclear. Using the experimental autoimmune encephalomyelitis (EAE) model, we report that memory Th17 cells rapidly expanded in response to rechallenge and migrated to the CNS in high numbers, resulting in earlier onset and increased severity of clinical disease. Memory Th17 cells were generated from IL-17 + and RORgt + precursors, and the stability of the Th17 cell phenotype depended on the amount of time allowed for the primary response. IL-23 was required for this enhanced recall response. IL-23 receptor blockade did not directly impact IL-17 production, but did impair the subsequent proliferation and generation of effectors coexpressing the Th1 cell-specific transcription factor T-bet. In addition, many genes required for cell-cycle progression were downregulated in Th17 cells that lacked IL-23 signaling, showing that a major mechanism for IL-23 in primary and memory Th17 cell responses operates via regulation of proliferation-associated pathways.
INTRODUCTION
The generation of memory T cells is an extremely useful event for providing protective immunity to infectious agents. Autoimmunity, on the other hand, represents a situation in which the generation of memory cells contributes to ongoing or recurring disease. T helper 17 (Th17) cells are now strongly associated with many human autoimmune and chronic inflammatory disorders, including psoriasis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, and uveitis (Korn et al., 2009; McGeachy and Cua, 2008) . In mouse models of these diseases, Th17 cells have been shown to play a causative role. Many advances have been made in our understanding of how Th17 cell activation is regulated (reviewed extensively elsewhere; Boniface et al., 2008; Korn et al., 2009) .
Th17 cell recall responses have been shown to be effective in vaccination models of Mycobacterium tuberculosis (Khader et al., 2007) , Coccidioides posadasii, Histoplasma capsulatum, Blastomyces dermatitidis (Wü thrich et al., 2011) , and Klebsiella pneumoniae , as well as following infection with Bordetella pertussis (Warfel and Merkel, 2012) , Group A Streptococcus (Dileepan et al., 2011) , and Candida albicans (Herná ndez-Santos et al., 2012) . Th17 cells appear to be inherently plastic and easily convert to Th1, particularly in models of autoimmunity (Bending et al., 2009; Hirota et al., 2011; Lee et al., 2009; Martin-Orozco et al., 2009) , which would suggest that the subsequent memory response would be dominated by Th1 cells. However, the characteristics of autoimmune memory Th17 cell responses and requirements for interleukin 23 (IL-23) have so far not been addressed.
Previous work from our laboratory showed that the IL-23 receptor (IL-23R) is required in vivo for effector Th17 cell responses (McGeachy et al., 2009) . The requirement for IL-23 in the primary Th17 cell response might suggest that memory responses would be impaired if IL-23 was absent at this stage. In the absence of IL-23R, activated Th17 cells retain low IL-7Ra expression (McGeachy et al., 2009 ), a receptor that is known to be important for the survival of memory cells in CD8 populations (Kaech et al., 2003) and is also required for susceptibility to the experimental autoimmune encephalomyelitis (EAE) model (Walline et al., 2011) . On the other hand, it was recently shown that IL-7Ra does not delineate precursors that form CD4 + T cell memory (Marshall et al., 2011) . It remains controversial whether memory cells emerge from effector cell populations or less differentiated cells; a weak effector response could therefore predict either a poor or an enhanced memory response. Finally, IL-23R blockade 1 week after immunization is not effective in blocking the subsequent Th17 effector cell response in EAE, suggesting that memory Th17 cells may also not require IL-23 for their subsequent reactivation in vivo. Therefore, we set out to investigate the requirements for IL-23
in autoimmune Th17 cell memory responses using an adapted model of EAE. postimmunization, reaching a peak in the lymph nodes (LNs) at day 7 ( Figure 1C) , with a large increase in CD44 hi CD27 lo effectors ( Figure 1D ) that produce IL-17 ( Figure 1E ). The proportion of interferon-g + (IFNg + ) cells also increased over time, as has been reported to occur in the primary Th17 cell response (Hirota et al., 2011) . Hence, it appeared that memory for Th17 cells was stable in this system, in the sense that most of the cells initially produced IL-17 and IFNg emerged later.
RESULTS AND DISCUSSION
The initial expansion in the LNs was followed by a large efflux of cells into the blood ( Figure 1F ) and infiltration into the CNS ( Figure 1G ). A comparison of transferred memory cells with endogenous primary activated cells in the CNS revealed that the memory cells were not only present at slightly higher frequencies but also produced more cytokine, particularly . These results show that memory Th17 cells can be generated and tracked in our system, and these cells strongly contribute to disease after re-exposure to antigen.
Memory Cells Are Generated from IL-17 + and RORgt
+ Precursors
Whether memory CD4 + T cells are generated from effectors or noncommitted Th0 cell precursors remains controversial, but for Th1 cells, Yeh et al. (2011) demonstrated that memory cells are generated from IFNg + precursors. Also, Th17 cells have been proposed to be inherently plastic, readily converting to Th1. Therefore, we asked whether the IL-17 + memory cells we observed were derived from the original IL-17-producing cells present in the primary response by using IL-17-GFP reporter mice as donors and sorting GFP + cells on day 8 postimmunization ( Figure S2 ). Recipients of IL-17-GFP + cells consistently showed a faster onset and increased severity of clinical scores compared with recipients of IL-17-GFP À cells (Figure 2A) , and IL-17-GFP + cells
were present in high numbers in the CNS, whereas few IL-17-GFP À transfer cells were present at that site ( Figure 2B ). By day 11 of the secondary response, we found that most of the originally IL-17-GFP + cells were no longer producing IL-17 in the CNS and were instead positive for IFNg ( Figure 2C Figure 2F ), followed by a small increase in IFNg-producing cells. The cells that had maintained RORgt in the secondary response were also the main producers of IL-17, with a small proportion of double producers, whereas cells that had downregulated RORgt produced some IFNg but little IL-17 ( Figure 2G ). Corresponding with the increase in IFNg, many of the previously RORgt + cells expressed T-bet on day 13 ( Figure 2H ). However, many RORgt + IL-17 + cells were also T-bet + ( Figure 2I ), suggesting that RORgt and T-bet expression are not necessarily mutually exclusive in Th17 cells. Although these data confirm the inherently plastic nature of Th17 cells, they also suggest that the memory population is either generated before the conversion of effectors toward a Th1 phenotype or that Th17 memory cells survive more readily than ''ex-Th17'' Th1 cells, since the memory response is characterized by the appearance of IL-17 producers before IFNg producers. Figure 3C ), which was particularly apparent at the peak of LN expansion and corresponded with a reduced frequency of CD44 hi CD27 lo effector cells ( Figure 3D ) and few transferred memory cells infiltrating the CNS ( Figure 3E ). Transfer of cells into IL-23R À/À naive recipient mice, in which endogenous T cells do not form effector Th17 responses (McGeachy et al., 2009) , resulted in a disease course similar to transfer into wild-type (WT) hosts ( Figure S4A ), and this was effectively blocked by anti-IL-23R treatment. Furthermore, memory cells induced EAE in RAG-deficient animals that lack endogenous T cells, and these effects were also dependent on IL-23 (Figure S4B) , confirming that these transferred Th17 memory cells alone are sufficient to initiate EAE when activated in the presence of IL-23. Given that MOG is a self-antigen, we also tested whether similar IL-23-dependent Th17 memory responses could be induced using the putative nonself immunogenic representative dot plots and pooled data are shown. Day 0 is equivalent to unimmunized recipient of memory cell transfer.
IL-23 Is

(legend continued on next page)
peptide OVA(323-339) as the immunizing antigen. Indeed, we observed similar expansion and cytokine production by transferred T cells in this OVA-driven recall assay ( Figure S5 ).
Anti-IL-23R Inhibits the Generation of Large Numbers of Cytokine-Producing Effector Cells
We previously reported that IL-23R blockade during the primary response both reduced the percentage of IL-17 + cells in the periphery and impaired the resulting effector response (McGeachy et al., 2009 ). In contrast, in the present study, IL-23R blockade did not reduce the percentage of IL-17 producers during the memory response ( Figure 4A ), and instead drastically reduced the absolute number of IL-17 + cells ( Figure 4B ). The IL-17 + IFNg + and IL-17 À IFNg + populations were also reduced in both percentage and number at day 7 in the LNs (Figures 4C and 4D) . It was recently reported that IL-23 is required for granulocyte-macrophage colony-stimulating factor (GM-CSF) production by Th17 cells in EAE (Codarri et al., 2011; El-Behi et al., 2011) . In our memory population, GM-CSF producers were not significantly reduced as a percentage of memory cells ( Figure 4E ). However, similarly to IL-17, there was a significant decrease in the absolute numbers of GM-CSF + cells when anti-IL-23R was administered ( Figure 4F ). In the target tissue (CNS), the percentage of memory cells producing IL-17 was again not different, but IL-17 + IFNg + and IL-17 À IFNg + cells were reduced with anti-IL-23R ( Figure 4G ). Corresponding with reduced IFNg, T-bet expression was also reduced when IL-23 signals were blocked during the secondary response ( Figure 4I ). Similar reductions in T-bet expression by primary Th17 cells activated in IL-23 knockout mice were recently reported (Hirota et al., 2011) . Therefore, induction of T-bet and IFNg appear to be part of the Th17 program initiated by IL-23 in vivo. Interestingly, Yeh et al. (2011) reported that IL-12 is not required for T-bet expression in EAE.
It remains unclear what the functions of T-bet and IFNg are in Th17 cells. Although T-bet is thought to be required for autoimmune inflammation , IFNg is not, at least in commonly used models. It was recently proposed that T-bet inhibits RORgt in Th17 cells through binding to the cofactor RUNX1 , and T-betdeficient animals do have increased numbers of IL-17 + cells despite their resistance to autoimmunity. However, it is clear that in human chronically inflamed tissues, such as the inflamed colon in Crohn's disease or brain lesions in multiple sclerosis, these double-producing cells are found in high numbers (Kebir et al., 2009; Kleinschek et al., 2009 ). In our study we also observed a high frequency of double-positive cells expressing RORgt and T-bet as well as IL-17 and IFNg, and this coexpression was dependent on IL-23, suggesting a proinflammatory role for these cells. Furthermore, a high proportion of RORgt + T-bet + cells produced IL-17 but not IFNg in vivo. Therefore, the relationship between T-bet and Th17 cells warrants further investigation.
Anti-IL-23R Reduces the Number of Proliferating Memory Cells
The findings so far suggest that IL-23 is required for the memory Th17 response, but not necessarily for production of IL-17 or other Th17-associated factors. Rather, the biggest defect appeared to be in the number of cells generated, suggesting a proliferation defect. Analysis of Ki67 expression in the memory cells confirmed that proliferation was indeed being affected by IL-23R blockade ( Figure 5A ). Since we previously observed that IL-23 drives expansion of effector Th17 cells in the primary response (McGeachy et al., 2009) , we turned to a system that allowed more in-depth analysis of the effects of IL-23 on proliferation. Using adoptive transfer of OTII cells, which have a transgenic T cell receptor specific for OVA(323-339), we were able to generate activated cells (all CD44 hi ) by immunizing recipients as previously described (McGeachy et al., 2009) . We then sorted the OTII cells based on IL-17 expression for messenger RNA (mRNA) analysis. By comparing IL-17 + and IL-17 À cells derived from the same antigen-specific activated T cell population, we were able to ask which genes were differentially regulated. Il17a was increased in IL-17 + cells, confirming sort purity ( Figure 5B ). Ki67 was also upregulated in IL-17 + cells and reduced in IL-23R-deficient cells, as expected ( Figure 5C ). Furthermore, Il23ra expression correlated with Il17 expression, being increased on IL-17 + cells compared with IL-17 À cells, further confirming that IL-23 signaling drives proliferation in Th17 cells ( Figure 5D ). We then investigated the expression of genes that are involved in cell cycle. Many of these genes were indeed upregulated in IL-17 + cells compared with IL-17 À cells ( Figure 5E ). These included genes for transcription factors that regulate cell-cycle progression (E2F, Tfdp, Myb, cdc, and cyclin families), genes for enzymes required for DNA replication (polymerases, ligases, and primases) as well as DNA repair proteins of the Brca and Chk families, and genes involved in chromosome assembly and segregation during division (Cenp, Kif, Haus, and Ncap families). The expression pattern of Il23ra À/À IL-17 + cells showed that there was at least a 2-fold downregulation in almost all cell-cycle genes that were associated with WT IL-17 + cells ( Figure 5F ). Not all genes were downregulated in the Il23ra See also Figure S1 .
sorted from memory populations activated in vivo in the presence of anti-IL-23R or an isotype control antibody. Again, gene expression for Il-17a was not different between the two populations, confirming the sort integrity ( Figure 5G ). Il21 and Il1r1 expression were not significantly altered by IL-23R blockade ( Figures 5H and 5I ), suggesting that IL-23 is not absolutely required for production of IL-21 or responsiveness Figure S2 .
to IL-1R1, two factors known to be required for Th17 development in vivo (Korn et al., 2007; Nurieva et al., 2007; Sutton et al., 2006) . A similar pattern of cell-cycle-associated gene downregulation was observed in memory IL-17 + cells that had been activated in vivo in the absence of IL-23 signals ( Figure 5J ). IL-23 could regulate these proliferation-associated genes directly or indirectly by activating ''intermediary'' transcription factors. We therefore asked which of the genes we had identified were upregulated within a short time frame and therefore likely and E2f2 were rapidly upregulated in response to IL-23 ( Figures  5K-5M ). The function of these genes remains to be tested, but these data strongly suggest that many of the genes that require IL-23R expression are activated indirectly, and that IL-23 activates key transcription factors in addition to STAT3 to mediate its downstream proliferation effects. When we compare the primary and secondary requirements for activation of Th17 cells, it is clear that IL-23 is important for both stages. Blockade of IL-23 resulted in fewer effector cells migrating to the blood and tissues, as well as fewer IFNg + cells, and this was associated with reduced proliferation in both the primary and recall responses, although the effects on proliferation were most pronounced in the memory response. Although we did not find regulation of the antiapoptotic factor Bcl2, the observed reduction of multiple proteins required for DNA repair pathways, such as BRCA1 and BRCA2, would increase the susceptibility of dividing cells to apoptosis, further reducing the number of cycling cells when IL-23 is absent. In this regard, it is interesting that IL-1, another cytokine that is critical for Th17 development in both mice and humans, has been shown to promote proliferation of Th17 cells through activation of the mTOR pathway (Gulen et al., 2010) . IL-1 is required early in Th17 development , whereas the effects of IL-23 become more apparent later (McGeachy et al., 2009 ). Whether IL-1 and IL-23 cooperate directly to promote proliferation or act at different stages of development remains unclear. Kryczek et al. (2011) recently characterized memory Th17 cells found in three types of chronic inflammation of the digestive system in human patients: chronic graft-versus-host disease, ulcerative colitis, and colon cancer. They found that Th17 cells were a more stable population than was previously reported, in agreement with our finding that the IL-17-producing Th17 phenotype was recapitulated in the memory response. Supporting the role of human Th17 memory cells in chronic disease, Kryczek et al. also reported that these cells appear to be a robust population that is resistant to apoptosis and is associated with high expression of the antiapoptotic genes BCLXL and Bcl2. In their experiments, viability was not influenced by IL-23; rather, HIF1 was proposed to regulate Bcl2. Importantly, human Th17 memory cells were also found to have greater proliferative capacity than other subsets. In our system, we also found that autoimmune IL-17 + cells had increased proliferation compared with their IL-17 À counterparts, and further demonstrated that multiple cell-cycleassociated genes were strongly regulated by IL-23. Therefore, our results correspond with and extend findings that are emerging from studies of human samples, and highlight the potential therapeutic utility of neutralizing IL-23 in chronic inflammatory and autoimmune diseases associated with memory Th17 cells.
EXPERIMENTAL PROCEDURES Mice
Il23ra
-/-OTII + CD45.1 + mice (Chan et al., 2006) were generated at Merck (Palo Alto, CA, USA). C57Bl/6 and CD45.1 + mice purchased from The Jackson Laboratory (Bar Harbor, ME, USA). IL-17-GFP reporter mice were purchased from Biocytogen (Worcester, MA, USA). RORgt-GFP reporter mice were a kind gift from Dr. Gerard Eberl (Institut Pasteur, Paris). The animals were housed in an AAALAC-approved facility and procedures were approved by the Merck Palo Alto IACUC committee. EAE Induction EAE was induced 2-3 weeks following transfer of memory cells. Recipient mice or untransferred controls were immunized with 100 mg MOG(35-55) in 200 ml CFA containing 100 mg heat-killed M. tuberculosis H37Ra in four sites on the back and received 100 ng pertussis toxin (List Biological Laboratories, Campbell, CA, USA) intraperitoneally on days 0 and 2. EAE was assessed according to the following clinical grades: 1 = flaccid tail; 2 = impaired righting reflex and hindlimb weakness; 3 = partial hindlimb paralysis; 4 = complete hindlimb paralysis; 5 = hindlimb paralysis with partial forelimb paralysis; 6 = moribund/dead. Mouse anti-mouse IL-23R monoclonal antibody (21A4) and isotype control (27F11, mouse IgG1) were generated at Merck, and 700 mg/mouse was administered intraperitoneally.
Memory Cell Transfers
Flow Cytometry
LNs, blood, and CNS mononuclear cells were isolated as previously described (Cua et al., 2003; Langrish et al., 2005 ) from mice with EAE and single-cell suspensions were obtained. For cytokine analysis, cells were cultured in complete medium (RPMI media containing 10% fetal calf serum supplemented with Pen-Strep, L-Glutamine, HEPES, sodium pyruvate, and 2-ME) with 50 ng/ml phorbol myristate acetate (PMA) and 500 ng/ml ionomycin (both SigmaAldrich, St. Louis, MO, USA) in the presence of Golgiplug (BD Biosciences, San Jose, CA, USA) for 3-4 hr, followed by fluorescence-activated cell sorting (FACS) staining and analysis. The following FACS antibodies were purchased from BD Biosciences: CD4 (RM4-5), CD45.1 (A20), CD45.2(104) CD44 (IM7), CD27 (LG.3A10), CCR6 (140706), Ki67 (B56), IFN-g (XMG1.2), IL-17 (TC11-18H10), and IL-2 (JES6-5H4). Ki67 and intracellular cytokine staining were performed using the Cytofix/Cytoperm kit (BD) according to the manufacturer's instructions. T-bet (eBio4B10) and GM-CSF (MP1-22E9) were purchased from eBioscience. (K-M) IL-17-GFP reporter mice were immunized with MOG(35-55) in CFA and dLNs were harvested on day 4. Cells were stimulated with IL-23 or IL-6 for 2 hr and FACS sorted based on GFP; expression of the indicated cell-cycle genes was analyzed by RT-PCR. Data shown are representative of three independent experiments (A-F) or from two independent experiments (J-M) with at least four mice per group; bars on graphs show mean and SD. See also Figure S1 .
OTII Cell Transfer and Sorting
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